ADD MEETING LINK: https://teams.microsoft.com/meet/233038811840494?p=FWXDk63PPTu5b5gjNQ

OBJECTIVES: Upon completion of this activity, the participant should be able to:
1. Describe the pharmacology of kratom, including its major alkaloids, receptor mechanisms, and dose-dependent clinical effects.
2. Identify the health risks, toxicities, and potential for dependence associated with kratom and kratom-derived products.
3. Summarize the current regulatory landscape surrounding kratom and apply harm-reduction principles to the clinical management of kratom use disorder.

FACULTY DISCLOSURE: Celine Lee, MD has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.